{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:35:54Z","timestamp":1788471354407,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-025-02770-0","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:56:25Z","timestamp":1765270585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk of cardiovascular-related death after radiotherapy for thoracic cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhaoyuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunchen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"1","key":"2770_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024, Jan-Feb;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2770_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.canrad.2021.10.008","volume":"26","author":"A Latr\u00e8che","year":"2022","unstructured":"Latr\u00e8che A, Bourbonne V, Lucia F. Unrecognized thoracic radiotherapy toxicity: a review of literature. Cancer Radiother. 2022, Jun;26(4):616\u201321. https:\/\/doi.org\/10.1016\/j.canrad.2021.10.008.","journal-title":"Cancer Radiother"},{"issue":"13","key":"2770_CR3","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1200\/jco.2016.70.0229","volume":"35","author":"K Wang","year":"2017","unstructured":"Wang K, Eblan M, Deal A, et al. Cardiac toxicity after radiotherapy for stage iii non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy. J Clin Oncol Off J Am Soc Of Clin Oncol. 2017;35(13):1387\u201394. https:\/\/doi.org\/10.1200\/jco.2016.70.0229.","journal-title":"J Clin Oncol Off J Am Soc Of Clin Oncol"},{"issue":"4","key":"2770_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.currproblcancer.2018.05.008","volume":"42","author":"M Armanious","year":"2018","unstructured":"Armanious M, Mohammadi H, Khodor S, Oliver D, Johnstone P, Fradley M. Cardiovascular effects of radiation therapy. Curr Probl In Cancer. 2018;42(4):433\u201342. https:\/\/doi.org\/10.1016\/j.currproblcancer.2018.05.008.","journal-title":"Curr Probl In Cancer"},{"key":"2770_CR5","doi-asserted-by":"publisher","unstructured":"Talebi A, Bitarafan-Rajabi A, Alizadeh-Asl A, et al. Machine learning based radiomics model to predict radiotherapy induced cardiotoxicity in breast cancer. J Appl Clin Med Phys. 2024 Dec, 20;e14614. https:\/\/doi.org\/10.1002\/acm2.14614.","DOI":"10.1002\/acm2.14614"},{"issue":"6","key":"2770_CR6","doi-asserted-by":"publisher","first-page":"e023802","DOI":"10.1161\/jaha.121.023802","volume":"11","author":"E Liu","year":"2022","unstructured":"Liu E, Guan X, Wei R, et al. Association between radiotherapy and death from cardiovascular disease among patients with cancer: a large population-based cohort study. J Am Heart Assoc. 2022;11(6):e023802. https:\/\/doi.org\/10.1161\/jaha.121.023802.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"2770_CR7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.clon.2024.09.001","volume":"36","author":"GM Walls","year":"2024","unstructured":"Walls GM, Mitchell JD, Lyon AR, Harbinson M, Hanna GG. Radiation oncology opinions and practice on cardiotoxicity in lung cancer: a cross-sectional study by the International Cardio-oncology society. Clin Oncol (R Coll Radiol). 2024, Dec;36(12):745\u201356. https:\/\/doi.org\/10.1016\/j.clon.2024.09.001.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"2770_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/187152911798347052","volume":"11","author":"L Mancuso","year":"2011","unstructured":"Mancuso L, Mancuso A, Scordato F, Pieri M, Eliana Valerio MC. Malignancy and radiation-induced cardiotoxicity. Cardiovasc Hematol Disord Drug Targets. 2011;11(2):102\u201308. https:\/\/doi.org\/10.2174\/187152911798347052.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"20","key":"2770_CR9","doi-asserted-by":"publisher","first-page":"e036411","DOI":"10.1161\/jaha.124.036411","volume":"13","author":"YJ Huang","year":"2024","unstructured":"Huang YJ, Lin JA, Chen WM, Shia BC, Wu SY. Statin therapy reduces radiation-induced cardiotoxicity in patients with breast cancer receiving adjuvant radiotherapy. J Am Heart Assoc. 2024, Oct, 15;13(20):e036411. https:\/\/doi.org\/10.1161\/jaha.124.036411.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"2770_CR10","doi-asserted-by":"publisher","first-page":"e20660","DOI":"10.1016\/j.heliyon.2023.e20660","volume":"9","author":"J Wang","year":"2023","unstructured":"Wang J, Zhao J, Meng Z, et al. ATP protects anti-PD-1\/radiation-induced cardiac dysfunction by inhibiting anti-PD-1 exacerbated cardiomyocyte apoptosis, and improving autophagic flux. Heliyon. 2023, Oct;9(10):e20660. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20660.","journal-title":"Heliyon"},{"key":"2770_CR11","doi-asserted-by":"publisher","unstructured":"Qiu Y, Xie X, Lin L. circFOXO3 protects cardiomyocytes against radiation\u2011induced cardiotoxicity. Mol Med Rep. 2021, Mar;23(3). https:\/\/doi.org\/10.3892\/mmr.2020.11816.","DOI":"10.3892\/mmr.2020.11816"},{"issue":"4","key":"2770_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaccao.2024.07.005","volume":"6","author":"KM Atkins","year":"2024","unstructured":"Atkins KM, Zhang SC, Kehayias C, et al. Cardiac substructure radiation dose and associations with tachyarrhythmia and bradyarrhythmia after lung cancer radiotherapy. JACC CardioOncol. 2024, Aug;6(4):544\u201356. https:\/\/doi.org\/10.1016\/j.jaccao.2024.07.005.","journal-title":"JACC CardioOncol"},{"issue":"6","key":"2770_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.cllc.2019.05.014","volume":"20","author":"JF Borkenhagen","year":"2019","unstructured":"Borkenhagen JF, Bergom C, Rapp CT, Klawikowski SJ, Rein LE, Gore EM. Dosimetric predictors of cardiotoxicity in thoracic radiotherapy for lung cancer. Clin Lung Cancer. 2019, Nov;20(6):435\u201341. https:\/\/doi.org\/10.1016\/j.cllc.2019.05.014.","journal-title":"Clin Lung Cancer"},{"issue":"6","key":"2770_CR14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jaccao.2023.08.007","volume":"5","author":"HJ No","year":"2023","unstructured":"No HJ, Guo FB, Park NJ, et al. Predicting adverse cardiac events after radiotherapy for locally advanced non-small cell lung cancer. JACC cardiooncol. 2023, Dec;5(6):775\u201387. https:\/\/doi.org\/10.1016\/j.jaccao.2023.08.007.","journal-title":"JACC cardiooncol"},{"issue":"6","key":"2770_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.20892\/j.issn.2095-3941.2022.0326","volume":"20","author":"J Luo","year":"2023","unstructured":"Luo J, Song J, Xiao L, et al. Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer. Cancer Biol Med. 2023, Jun, 9;20(6):452\u201364. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2022.0326.","journal-title":"Cancer Biol Med"},{"key":"2770_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.radonc.2020.09.050","volume":"152","author":"BS Jang","year":"2020","unstructured":"Jang BS, Cha MJ, Kim HJ, et al. Heart substructural dosimetric parameters and risk of cardiac events after definitive chemoradiotherapy for stage iii non-small cell lung cancer. Radiother Oncol. 2020, Nov;152:126\u201332. https:\/\/doi.org\/10.1016\/j.radonc.2020.09.050.","journal-title":"Radiother Oncol"},{"issue":"2","key":"2770_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/jamaoncol.2020.6332","volume":"7","author":"KM Atkins","year":"2021","unstructured":"Atkins KM, Chaunzwa TL, Lamba N, et al. Association of left anterior descending coronary artery radiation dose with Major adverse cardiac events and mortality in patients with non-small cell lung cancer. JAMA Oncol. 2021, Feb, 1;7(2):206\u201319. https:\/\/doi.org\/10.1001\/jamaoncol.2020.6332.","journal-title":"JAMA Oncol"},{"issue":"1","key":"2770_CR18","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1186\/s12885-024-13281-8","volume":"24","author":"M Locquet","year":"2024","unstructured":"Locquet M, Jacob S, Geets X, Beaudart C. Dose-volume predictors of cardiac adverse events after high-dose thoracic radiation therapy for lung cancer: a systematic review and meta-analysis. BMC Cancer. 2024, Dec, 20;24(1):1556. https:\/\/doi.org\/10.1186\/s12885-024-13281-8.","journal-title":"BMC Cancer"},{"issue":"1","key":"2770_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12872-024-03981-1","volume":"24","author":"R Liu","year":"2024","unstructured":"Liu R, Xu LA, Zhao Z, Han R. Application of two-dimensional speckle-tracking echocardiography in radiotherapy-related cardiac systolic dysfunction and analysis of its risk factors: a prospective cohort study. BMC Cardiovasc Disord. 2024, Jun, 27;24(1):328. https:\/\/doi.org\/10.1186\/s12872-024-03981-1.","journal-title":"BMC Cardiovasc Disord"},{"issue":"40","key":"2770_CR20","doi-asserted-by":"publisher","first-page":"e35104","DOI":"10.1097\/md.0000000000035104","volume":"102","author":"H Xing","year":"2023","unstructured":"Xing H, Wu C, Zhang D, Zhang X. Competing risk analysis of cardiovascular-specific mortality in typical carcinoid neoplasms of the lung: a seer database analysis. Med (baltim). 2023, Oct, 6;102(40):e35104. https:\/\/doi.org\/10.1097\/md.0000000000035104.","journal-title":"Med (baltim)"},{"key":"2770_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijcard.2021.02.025","volume":"330","author":"JY Sun","year":"2021","unstructured":"Sun JY, Zhang ZY, Qu Q, et al. Cardiovascular disease-specific mortality in 270,618 patients with non-small cell lung cancer. Int J Cardiol. 2021, May, 1;330:186\u201393. https:\/\/doi.org\/10.1016\/j.ijcard.2021.02.025.","journal-title":"Int J Cardiol"},{"key":"2770_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.radonc.2022.02.010","volume":"169","author":"MC Tjong","year":"2022","unstructured":"Tjong MC, Bitterman DS, Brantley K, et al. Major adverse cardiac event risk prediction model incorporating baseline cardiac disease, hypertension, and logarithmic left anterior descending coronary artery radiation dose in lung cancer (CHyLL). Radiother Oncol. 2022, Apr;169:105\u201313. https:\/\/doi.org\/10.1016\/j.radonc.2022.02.010.","journal-title":"Radiother Oncol"},{"key":"2770_CR23","doi-asserted-by":"publisher","first-page":"109719","DOI":"10.1016\/j.radonc.2023.109719","volume":"185","author":"A Olloni","year":"2023","unstructured":"Olloni A, Brink C, Lorenzen EL, et al. Does coronary artery calcium score have an impact on overall survival for locally advanced non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol. 2023, Aug;185:109719. https:\/\/doi.org\/10.1016\/j.radonc.2023.109719.","journal-title":"Radiother Oncol"},{"issue":"26","key":"2770_CR24","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1111\/1759-7714.15056","volume":"14","author":"SY Wang","year":"2023","unstructured":"Wang SY, Tsai WT, Lin KH, et al. Integrating subvolume dose and myocardial perfusion imaging parameters to assess the impact of radiation therapy on heart function in breast cancer patients: a comparative analysis between left- and right-sided breast cancer. Thorac Cancer. 2023, Sep;14(26):2696\u2013706. https:\/\/doi.org\/10.1111\/1759-7714.15056.","journal-title":"Thorac Cancer"},{"key":"2770_CR25","doi-asserted-by":"publisher","unstructured":"Guan T, Jiang Y, Luo Z, et al. Long-term risks of cardiovascular death in a population-based cohort of 1,141,675 older patients with cancer. Age Ageing. 2023, May, 1;52(5). https:\/\/doi.org\/10.1093\/ageing\/afad068.","DOI":"10.1093\/ageing\/afad068"},{"issue":"12","key":"2770_CR26","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/jocs.14299","volume":"34","author":"T Guan","year":"2019","unstructured":"Guan T, Li Y, Qiu Z, et al. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor. J Card Surg. 2019, Dec;34(12):1540\u201349. https:\/\/doi.org\/10.1111\/jocs.14299.","journal-title":"J Card Surg"},{"issue":"1","key":"2770_CR27","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/s41467-020-15639-5","volume":"11","author":"KC Stoltzfus","year":"2020","unstructured":"Stoltzfus KC, Zhang Y, Sturgeon K, et al. Fatal heart disease among cancer patients. Nat Commun. 2020, Apr, 24;11(1):2011. https:\/\/doi.org\/10.1038\/s41467-020-15639-5.","journal-title":"Nat Commun"},{"issue":"35","key":"2770_CR28","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1200\/jco.20.00264","volume":"38","author":"GM Dores","year":"2020","unstructured":"Dores GM, Curtis RE, Dalal NH, Linet MS, Morton LM. Cause-specific mortality following initial chemotherapy in a population-based cohort of patients with classical Hodgkin Lymphoma, 2000-2016. J Clin Oncol. 2020, Dec, 10;38(35):4149\u201362. https:\/\/doi.org\/10.1200\/jco.20.00264.","journal-title":"J Clin Oncol"},{"issue":"43","key":"2770_CR29","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1093\/eurheartj\/ehy167","volume":"39","author":"J Weberpals","year":"2018","unstructured":"Weberpals J, Jansen L, M\u00fcller OJ, Brenner H. Long-term heart-specific mortality among 347 476 breast cancer patients treated with radiotherapy or chemotherapy: a registry-based cohort study. Eur Heart J. 2018, Nov, 14;39(43):3896\u2013903. https:\/\/doi.org\/10.1093\/eurheartj\/ehy167.","journal-title":"Eur Heart J"},{"issue":"28","key":"2770_CR30","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1200\/jco.2014.60.3654","volume":"33","author":"C Fung","year":"2015","unstructured":"Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB. Cardiovascular disease mortality after chemotherapy or surgery for testicular nonseminoma: a population-based study. J Clin Oncol. 2015, Oct, 1;33(28):3105\u201315. https:\/\/doi.org\/10.1200\/jco.2014.60.3654.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2770_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/s1470-2045(14)71207-0","volume":"16","author":"JD Bradley","year":"2015","unstructured":"Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015, Feb;16(2):187\u201399. https:\/\/doi.org\/10.1016\/s1470-2045(14)71207-0.","journal-title":"Lancet Oncol"},{"key":"2770_CR32","doi-asserted-by":"publisher","unstructured":"Erratum: 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for Therapeutic radiology and oncology (ESTRO) and the International cardio-oncology society (IC-OS): developed by the task force on cardio-oncology of the European society of cardiology (ESC). Eur Heart J Cardiovasc Imag. 2023, May, 31;24(6):e98. https:\/\/doi.org\/10.1093\/ehjci\/jead080.","DOI":"10.1093\/ehjci\/jead080"},{"key":"2770_CR33","doi-asserted-by":"publisher","unstructured":"Picchio V, Gaetani R, Pagano F, et al. Early impairment of Paracrine and phenotypic features in resident cardiac mesenchymal stromal cells after thoracic radiotherapy. Int J Mol Sci. 2024, Mar, 1;25(5). https:\/\/doi.org\/10.3390\/ijms25052873.","DOI":"10.3390\/ijms25052873"},{"issue":"2","key":"2770_CR34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jtho.2020.11.002","volume":"16","author":"K Banfill","year":"2021","unstructured":"Banfill K, Giuliani M, Aznar M, et al. Cardiac toxicity of thoracic radiotherapy: existing evidence and future directions. J Thorac Oncol. 2021, Feb;16(2):216\u201327. https:\/\/doi.org\/10.1016\/j.jtho.2020.11.002.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"2770_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11883-019-0810-x","volume":"21","author":"R da Silva","year":"2019","unstructured":"da Silva R. Effects of radiotherapy in coronary artery disease. Curr Atheroscler Rep. 2019, Nov, 19;21(12):50. https:\/\/doi.org\/10.1007\/s11883-019-0810-x.","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"2770_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.radonc.2010.09.002","volume":"97","author":"J Yarnold","year":"2010","unstructured":"Yarnold J, Brotons MC. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol. 2010, Oct;97(1):149\u201361. https:\/\/doi.org\/10.1016\/j.radonc.2010.09.002.","journal-title":"Radiother Oncol"},{"issue":"4","key":"2770_CR37","first-page":"1135","volume":"5","author":"HP Rodemann","year":"1991","unstructured":"Rodemann HP, Peterson HP, Schwenke K, von Wangenheim KH. Terminal differentiation of human fibroblasts is induced by radiation. Scanning Microsc. 1991, Dec;5(4):1135\u201342; discussion 1142-3.","journal-title":"Scanning Microsc"},{"issue":"23","key":"2770_CR38","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.jacc.2019.03.500","volume":"73","author":"KM Atkins","year":"2019","unstructured":"Atkins KM, Rawal B, Chaunzwa TL, et al. Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer. J Am Coll Of Cardiol. 2019, Jun, 18;73(23):2976\u201387. https:\/\/doi.org\/10.1016\/j.jacc.2019.03.500.","journal-title":"J Am Coll Of Cardiol"},{"key":"2770_CR39","doi-asserted-by":"publisher","first-page":"103121","DOI":"10.1016\/j.critrevonc.2020.103121","volume":"156","author":"P Loap","year":"2020","unstructured":"Loap P, Kirov K, Kirova Y. Cardiotoxicity in breast cancer patients treated with radiation therapy: from evidences to controversies. Crit Rev Oncol Hematol. 2020, Dec;156:103121. https:\/\/doi.org\/10.1016\/j.critrevonc.2020.103121.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"2770_CR40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013, Mar, 14;368(11):987\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1209825.","journal-title":"N Engl J Med"},{"issue":"4","key":"2770_CR41","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jacc.2010.08.638","volume":"57","author":"K Bouillon","year":"2011","unstructured":"Bouillon K, Haddy N, Delaloge S, et al. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol. 2011, Jan, 25;57(4):445\u201352. https:\/\/doi.org\/10.1016\/j.jacc.2010.08.638.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2770_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10549-021-06412-3","volume":"191","author":"H Merzenich","year":"2022","unstructured":"Merzenich H, Baaken D, Schmidt M, et al. Cardiac late effects after modern 3D-conformal radiotherapy in breast cancer patients: a retrospective cohort study in Germany (ESCaRa). Breast Cancer Res Treat. 2022, Jan;191(1):147\u201357. https:\/\/doi.org\/10.1007\/s10549-021-06412-3.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02770-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02770-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02770-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:55:20Z","timestamp":1768366520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-025-02770-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2770"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02770-0","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"This study did not involve human participants or animals, and therefore, no ethical approval was required. All data used in this study were obtained from publicly available sources, and no individual-level data were accessed or analyzed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The views expressed in this article are solely those of the authors and do not necessarily reflect the official policy or position of any affiliated institutions or funding agencies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}